Water solubility has always been a key obstacle in pharmaceutical formulation, affecting formulation stability and drug bioavailability. Approaches for achieving complete dissolution often have disadvantages associated with the large quantities of required excipients. Nanosuspension, consisting essentially of pure anti hypertensive drug telmisartan with minimum amount of stabilizers was formulated for rapid dissolution, thus achieving pharmacokinetic properties similar to those of a solution.\[[@ref1][@ref2]\] Telmisartan is practically insoluble in water, has a high melting point (261 -- 263°c) and has a high log *P* value (7.7). Given these features, nanosuspension can be considered as an attractive formulation approach. Poloxamer 188, poloxamer 407, HPMC E 15, PVP K 30, poloxamer 188/poloxamer 407, poloxamer 188/HPMC E15 and poloxamer 188/HPMC E15-stabilized nanosuspension were produced on a laboratory scale using media milling. Zirconium oxide beads are used as milling media in research study.\[[@ref3]\]

Materials and Methods {#sec1-1}
=====================

Telmisartan was kindly provided by Sunij Pharama Pvt Ltd (Ahmedabad, Gujarat). Poloxamer 188 (Zydus Cadila Healthcare Ltd, Bavala, Gujarat) and Poloxamer 407 (Torrent Pharmaceuticals Ltd., Bhat, Gujarat) were commercially obtained. HPMC E15 and PVP K30 used were of laboratory grade. Zirconium oxide beads were kindly provided by Sun Pharma (Baroda, Gujarat). All other chemicals and solvents were of analytical reagent grade and deionized- distilled water was throughout the study.

Method {#sec2-1}
------

Nanosuspension was prepared using media milling. In 20 ml vial, solution of stabilizer was prepared in 10 ml water. 20 mg telmisartan was to prepare suspension. To this suspension, 15 gm of zirconium beads (Ø 0.8 mm) were added as a milling agent. Add a magnetic bead in to this vial and placed on the magnetic stirrer at 700 rpm for 18 hr. After milling, the vials were removed from the magnetic stirrer and the nanosuspension was separated from zirconium beads by decanting the suspension followed by washing of the beads with water.

Results and Discussion {#sec1-2}
======================

Prepared nanosuspension was evaluated for particle size measurement, zeta potential, dissolution study and morphological characterization. The milling process resulted in, particle size in the range of 200 nm-600 nm, polydispersity index in the range of 0.3 to 0.7 and zeta potential in the range of --6mV to 10mV. An observation shows higher dissolution rates in nanosized product compared to untreated physical mixture. For the nanosuspension, have excellent disintegration and high surface area of the telmisartan nanoparticles give rise to a dissolution profile showing complete dissolution within minutes.

Conclusion {#sec1-3}
==========

Media milling proved to be successful for the laboratory scale production of telmisartan nanosuspension. The process yielded nanosuspension with a mean particle size 450±35 nm, a mean polydispersity index 0.4±0.1 and zeta potential -6.0±0.5 mV. It is possible to transform the liquid nanosuspension formulation to solid powder. So the final product formulation should be the lyophilised nanopowder for getting the better stability during storage.
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